Live Quote · NASDAQNBSEHealthcare· Biotechnology

NeuBase Therapeutics, Inc.

$0.38▼ 1.56%($-0.01)
MKT CAP $1.42MLAST EARNINGS Aug 12, 2024
50%
Bullish
TickerSpark Score
50/100
▌ Mixed
100
Valuation
20
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NBSE research report →

Analyst RatingBuy
3 Buy3 Hold0 Sell

Price Chart

-89.20% · this period
$3.74$2.06$0.38May 25Nov 24May 24
52-Week Range0% of range
Low
$0.36
Current
$0.38
High
$4.44